triple hormone receptor agonist retatrutide for obesity Retatrutide: A Shaping the Future of Metabolic Care Retatrutide is a triple-agonist drug

IGF-1 and insulin share similar signaling pathways, particularly the PI3K and AKT pathways

Chung, J.-O., Lee, S.-B., Jeong, K.-H., Song, J.-H., Kim, S.-K., Joo, K.-M., Jeong, H.-W., Choi, J.-K., Kim, J.-K., Kim, W.-G., Shin, S.-S., & Shim, S.-M

RESEARCH USE ONLY NOT FOR HUMAN CONSUMPTION.

Article PubMed Google Scholar Download references Related Articles Arsenic-loving bacterium needs phosphorus after all Will you take the 'arsenic-life' test

Results may vary depending on individual diet, training, and lifestyle

SLU-PP-332 is a synthetic small-molecule compound studied for its potential influence on ERR (Estrogen-Related Receptor) pathways , which are closely linked to mitochondrial biogenesis and oxidative metabolism